2021
DOI: 10.1136/bcr-2021-243726
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19-associatedStaphylococcus aureuscavitating pneumonia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 10 publications
(12 reference statements)
0
4
0
Order By: Relevance
“…Viral pneumonia-causing cavitation is relatively uncommon [ 2 ]. Staphylococcus aureus , a known cause of community and hospital-associated infections was a major cause of mortality during the 1918 and 2009 influenza pandemics and is often seen as a secondary infection or superinfection but rarely seen as a coinfection in immunocompetent patients such as in this case [ 3 ]. Researchers have discovered that some MRSA strains contain genes for the Panton-Valentine leucocidin (PVL) toxin which has been shown to be responsible for many of the severe clinical symptoms of infection including severe necrotizing pneumonia and necrotic lesions of the skin and soft tissue [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…Viral pneumonia-causing cavitation is relatively uncommon [ 2 ]. Staphylococcus aureus , a known cause of community and hospital-associated infections was a major cause of mortality during the 1918 and 2009 influenza pandemics and is often seen as a secondary infection or superinfection but rarely seen as a coinfection in immunocompetent patients such as in this case [ 3 ]. Researchers have discovered that some MRSA strains contain genes for the Panton-Valentine leucocidin (PVL) toxin which has been shown to be responsible for many of the severe clinical symptoms of infection including severe necrotizing pneumonia and necrotic lesions of the skin and soft tissue [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies show that there is an increase in MRCoNS infections with rising COVID-19. MRSA is among the most frequent causative agents of pulmonary infection in patients with COVID-19 (Chandran et al, 2021;Bassetti et al, 2022). This might be due to immune compromisation, immune-related pathways and gene dysregulation in COVID-19 patients (Türk et al, 2020;Malkan et al, 2021;Türk et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Increased toxin production justifies the use of antibiotics for the treatment of necrotising pneumonia caused by this organism. Infection appears to be less common in patients with COVID-19 (7–14%) than in those with PVL-producing pneumonia, which has been described as a complication of this virus [ 124 , 125 , 126 ].…”
Section: Staphylococcus Aureusmentioning
confidence: 99%